Mark Hindle

Mark has been a CEO and executive director in many organisations for over 20 years after starting his career as a Microbiology BMS During the pandemic Mark played a vital role as Pathology Incident Director, working strategically at ICS level to ensure testing was used a vital part of prevention and control of illness Mark is passionate about involving people in strategic implementation and transforming services so the are more effective and more resilient Pathology plays a vital role in the patient journey and there are many opportunities to further develop POCT and new technologies to support elective restoration and continue to improve patient experience.